Global Health Limited (MEDANTA) reported consolidated revenue of INR 45,089 million for FY2026, up 19.6% y-o-y, with PAT growing 15.1%.
Akums Drugs and Pharmaceuticals Limited (AKUMS) reports Q4 FY26 results with 9.7% revenue growth and 61.6% EBITDA surge.
Senores Pharmaceuticals Limited (SENORES) reports strong Q4 & FY26 results with revenue up 66% and PAT surge of 219%.
Fischer Medical Ventures Limited (FISCHER) partners with WFNS Innovation & Technology Committee, marking a historic first in global neurosurgical innovation.
Indoco Remedies Limited (INDOCO) receives Malta Medicines Authority audit approval for its Baddi facility, confirming compliance with EU GMP standards.
Alembic Pharmaceuticals Limited (APLLTD) announced USFDA tentative approval for Darolutamide Tablets, 300 mg, with an estimated market size of US$ 3,155 million.
Metropolis Healthcare Limited (METROPOLIS) reports strong Q4 & FY26 results with revenue up 32% and PAT surging 23%.
Inventurus Knowledge Solutions Limited (IKS) reports robust FY26 financial results with 20% revenue growth and a 48% surge in Profit After Tax.
Lupin Limited (LUPIN) announced U.S. FDA approval for Famotidine Injection, expanding its pharmaceutical portfolio with a bioequivalent to Pepcid®.
Yatharth Hospital & Trauma Care Services Limited (YATHARTH) acquires a new 250-bed hospital in Gurugram, expanding its presence in the high-growth Delhi NCR healthcare market.